Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-15-129335
Filing Date
2015-04-14
Accepted
2015-04-14 16:11:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS SUPPLEMENT d909684d424b5.htm 424B5 416251
2 GRAPHIC g909684g56l71.jpg GRAPHIC 21299
  Complete submission text file 0001193125-15-129335.txt   446731
Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-203206 | Film No.: 15769353
SIC: 2834 Pharmaceutical Preparations